ADVANCING IMMUNO-ONCOLOGY
CLINICAL TRIALS

IOVANCE is conducting four Phase 2 clinical trials to assess the efficacy and safety of autologous Tumor Infiltrating Lymphocytes for treatment of patients with Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-Small Cell Lung Cancer (NSCLC) and Cervical Cancer.

C-144-01 is a multicenter clinical trial for patients with Metastatic Melanoma at various sites in the US and Europe.

C-145-03 is a multicenter clinical trial now recruiting patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) at various sites in the US.

C-145-04 is a multicenter clinical trial now recruiting patients with Cervical Carcinoma at various sites in the US and Europe.

IOV-COM-202 is a multicenter clinical trial now recruiting patients with Solid Tumors at various sites in the US.

Learn

Sign up for email alerts

Be the first to receive breaking news

Join